FDA OKs Botox Alternative… And Issues Warnings for Both

The FDA has approved Dysport to treat forehead wrinkles and frown lines, making it only the second drug to be approved by the agency as a wrinkle treatment.

Dysport (formerly known as Reloxin) is made from the same active ingredient as Botox (made by Allergan), Clostridium botulinim toxin type A. Botulinum toxins temporarily reduce the appearance of wrinkles by restricting the muscle actions that cause creasing and frown lines.

Like Botox, Dysport is administered via an injection at the site of forehead wrinkles.  …

The most common side effects of Dysport are nose and throat irritation, headache, pain and skin reaction at the injection site, upper respiratory tract infection, eyelid swelling or drooping, sinus inflammation, and nausea.

Yesterday, the FDA also announced that it will require a black box label for all botulism-based drugs, including Dysport and Botox, warning of a rare but potentially life-threatening complication when the effects of the toxin spread from the injection site.

via WebMD:  FDA Approves New Wrinkle Treatment

Feel lucky enough to roll the dice for vanity? Dysport should hit the market in 30 to 60 days under the name Medicis.


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s